Advanced Cell Technology’s Robust Cell Reprogramming/Transdifferentiation Platform Well Positioned To Capitalize on Emerging Trends in Regenerative Medicine

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. “ACT” (OTCBB:ACTC) provides an update today on its plans to utilize its transdifferentiation platform to enhance regenerative medicine. Transdifferentiation involves reprogramming one type of adult cell, such as skin, into an altogether different type of cell, such as muscle or insulin-producing cells, without having to generate stem cells. This month scientists successfully turned ordinary fibroblasts into beating heart cells (

For more information, please visit
http://www.businesswire.com/news/home/20100830005798/en

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

VOCAPIA and SYSTRAN demonstrate an automated speech translation solution at EUROSATORY 2016 - GlobeNewswire (press release) views: 1541

Instagram is adding automatic in-app text translation - The Verge views: 1529

Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1526

F.A.Q. | Terms and conditions